OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Comprehensive RNA Study to Identify circRNA and miRNA Biomarkers for Docetaxel Resistance in Breast Cancer
Peide Huang, Fengyu Li, Zongchao Mo, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 23

Showing 23 citing articles:

Circular RNAs as Potential Biomarkers in Breast Cancer
Fatima Domenica Elisa De Palma, Francesco Salvatore, Jonathan Pol, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 725-725
Open Access | Times Cited: 37

Unveiling Pharmacogenomics Insights into Circular RNAs: Toward Precision Medicine in Cancer Therapy
Saud Alqahtani, Taha Alqahtani, Krishnaraju Venkatesan, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 535-535
Open Access

Circular RNA, A Molecule with Potential Chemistry and Applications in RNA-based Cancer Therapeutics: An Insight into Recent Advances
Zahra Shafaghat, Safa Radmehr, Saber Saharkhiz, et al.
Topics in Current Chemistry (2025) Vol. 383, Iss. 2
Open Access

Circular RNA EPHA3 suppresses progression and metastasis in prostate cancer through the miR-513a-3p/BMP2 axis
Huan Feng, Zhiyao Deng, Wei Peng, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9

Docetaxel-loaded nanoformulations delivery for breast cancer management: Challenges, recent advances, and future perspectives
Vijay Kumar Panthi, Saroj Bashyal, Keshav Raj Paudel
Journal of Drug Delivery Science and Technology (2023) Vol. 92, pp. 105314-105314
Closed Access | Times Cited: 9

circRNAs in drug resistance of breast cancer
Sema Mısır, SERAP OZER YAMAN, Nina Petrović, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2022) Vol. 30, Iss. 4, pp. 157-172
Open Access | Times Cited: 13

LncRNA LINC00184 promotes docetaxel resistance and immune escape via miR-105-5p/PD-L1 axis in prostate cancer
Wei Zhang, Jun Xin, Jinjin Lai, et al.
Immunobiology (2021) Vol. 227, Iss. 1, pp. 152163-152163
Closed Access | Times Cited: 18

Mechanical Ventilation-Related High Stretch Mainly Induces Endoplasmic Reticulum Stress and Thus Mediates Inflammation Response in Cultured Human Primary Airway Smooth Muscle Cells
Chongxin Yang, Jia Guo, Kai Ni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3811-3811
Open Access | Times Cited: 7

Resistance of breast cancer cells to paclitaxel is associated with low expressions of miRNA-186 and miRNA-7
V. S. Apollonova, Даниил Сергеевич Плевако, Alexandr Garanin, et al.
Cancer Drug Resistance (2023), pp. 596-610
Open Access | Times Cited: 5

Epigenetic Regulation in Exposome-Induced Tumorigenesis: Emerging Roles of ncRNAs
Miguel Ángel Olmedo-Suárez, Ivonne Ramírez‐Díaz, Andrea Pérez-González, et al.
Biomolecules (2022) Vol. 12, Iss. 4, pp. 513-513
Open Access | Times Cited: 7

Circular RNAs in the chemoresistance of triple‐negative breast cancer: A systematic review
Hongmei Wang, Xuefeng Shan, Yang Peng, et al.
Drug Development Research (2023) Vol. 84, Iss. 5, pp. 805-814
Closed Access | Times Cited: 4

Circular RNAs as a novel molecular mechanism in diagnosis, prognosis, therapeutic target, and inhibiting chemoresistance in breast cancer
Nafiseh Tashakori, M. V. Mikhailova, Zainab Abbas Mohammedali, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155569-155569
Closed Access | Times Cited: 1

CircRNA CircABCB1 Diminishes the Sensitivity of Breast Cancer Cells to Docetaxel by Sponging MiR-153-3p
Jiaqi Liu, Linna Kong, Wenqing Bian, et al.
The Tohoku Journal of Experimental Medicine (2023) Vol. 261, Iss. 1, pp. 25-33
Open Access | Times Cited: 3

Circular RNAs: novel regulators of resistance to systemic treatments in breast cancer
Xiaoqiang Guo, Yuming Hua
Neoplasma (2022) Vol. 69, Iss. 05, pp. 1019-1028
Open Access | Times Cited: 4

Circular RNA ATP2C1 (has_circ_0005797) sponges miR-432/miR-335 to promote breast cancer progression through regulating CCND1 expression.
Caiping Chen, Jianju Lu, Wang Li, et al.
PubMed (2023) Vol. 13, Iss. 8, pp. 3433-3448
Closed Access | Times Cited: 2

Enhancing drug and cell line representations via contrastive learning for improved anti-cancer drug prioritization
Patrick J. Lawrence, Benjamin Burns, Xia Ning
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access

Nitric Oxide-Releasing Docetaxel Prodrug Nanoplatforms for Effective Cancer Therapy
Leilei Gao, Fang Wang, Tingting Hou, et al.
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 2

Nitric oxide-releasing docetaxel prodrug nanoplatforms for effective cancer therapy
Leilei Gao, Fang Wang, Tingting Hou, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 75, pp. 103662-103662
Closed Access | Times Cited: 2

A Review of Potential Roles for Micro RNAs as Drugs Sensitivity Biomarkers in Breast Cancer
Monika Barsagade, Ravi Kishore Agrawal, Fouad Saleh, et al.
Journal of Angiotherapy (2023) Vol. 7, Iss. 2
Open Access

Page 1

Scroll to top